Stocks / BMRN / Shares Outstanding

BioMarin Pharmaceutical Inc. Shares Outstanding 2008–2025

BioMarin Pharmaceutical Inc. reported 192.3M of shares outstanding for fiscal 2025. That was 0.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +5.8%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details.

Latest filed value
192.3M
One-year change
+0.8%
Change since 2020
+5.8%
Latest period end
2025-12-31
BioMarin Pharmaceutical Inc. Shares Outstanding history from 2008 to 2025FY 2008: 0FY 2009: 100961922FY 2010: 110634465FY 2011: 114789732FY 2012: 125809162FY 2013: 143463668FY 2014: 149093647FY 2015: 161526044FY 2016: 172647588FY 2017: 175843749FY 2018: 178252954FY 2019: 179838114FY 2020: 181740999FY 2021: 183912514FY 2022: 186250719FY 2023: 188598154FY 2024: 190761349FY 2025: 192300101
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearShares OutstandingChange (YoY)
FY 2025192.3M+0.8%
FY 2024190.8M+1.1%
FY 2023188.6M+1.3%
FY 2022186.3M+1.3%
FY 2021183.9M+1.2%
FY 2020181.7M+1.1%
FY 2019179.8M+0.9%
FY 2018178.3M+1.4%
FY 2017175.8M+1.9%
FY 2016172.6M+6.9%
FY 2015161.5M+8.3%
FY 2014149.1M+3.9%
FY 2013143.5M+14.0%
FY 2012125.8M+9.6%
FY 2011114.8M+3.8%
FY 2010110.6M+9.6%
FY 2009101.0M—
FY 20080.0M—

Source: BioMarin Pharmaceutical Inc. SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BMRN 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

BioMarin Pharmaceutical Inc. reported 192.3M of shares outstanding for fiscal 2025. That was 0.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +5.8%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for BioMarin Pharmaceutical Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

BioMarin Pharmaceutical Inc. — frequently asked questions

What is BioMarin Pharmaceutical Inc.'s shares outstanding?

BioMarin Pharmaceutical Inc. (BMRN) reported shares outstanding of 192.3M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from BioMarin Pharmaceutical Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.

More BMRN financial history

BMRN revenueBMRN net incomeBMRN gross profitBMRN eps (earnings per share)BMRN ebitdaBMRN free cash flowBMRN total debtBMRN dividend historyBMRN p/e ratio

Full BMRN fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →